Acetylated tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32

Journal of Virology

Volumn 80, Issue 7, 2006, Pages 3189-3204

  Berro, Reem ^a   Kehn, Kylene ^b   De La Fuente, Cynthia ^b   Pumfery, Anne ^b,g   Adair, Richard ^c,h   Wade, John ^d   Colberg Poley, Anamaris M ^c   Hiscott, John ^e   Kashanchi, Fatah ^a,b,f  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MCGILL UNIVERSITY   (Canada)

^f J CRAIG VENTER INSTITUTE   (United States)

^g SETON HALL UNIVERSITY   (United States)

^h INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; LUCIFERASE; LYSINE; PROTEIN P32; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACETYLATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLADISTICS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; RNA SPLICING; VIRUS GENOME; VIRUS TRANSCRIPTION;

ACETYLATION; CARRIER PROTEINS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HUMANS; LUCIFERASES; MICROSCOPY, CONFOCAL; MITOCHONDRIAL PROTEINS; MODELS, GENETIC; PROTEOMICS; RNA SPLICING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645292647     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.7.3189-3204.2006     Document Type: Article

References (107)

1. Adair, R., G. W. Liebisch, Y. Su, and A. M. Colberg-Poley. 2004. Alteration of cellular RNA splicing and polyadenylation machineries during productive human cytomegalovirus infection. J. Gen. Virol. 85:3541-3553.
2. Balasubramanyam, K., R. Varier, M. Altaf, V. Swaminathan, N. Siddappa, U. Ranga, and T. Kundu. 2004. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279:51163-51171.
3. Benkirane, M., R. F. Chun, H. Xiao, V. V. Ogryzko, B. H. Howard, Y. Nakatani, and K. T. Jeang. 1998. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273:24898-24905.
4. Bieniasz, P., and B. Cullen. 2000. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74:9868-9877.
5. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7056-7065.
6. Bohan, C. A., F. Kashanchi, B. Ensoli, L. Buonaguro, K. A. Boris-Lawrie, and J. N. Brady. 1992. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr. 2:391-407.
7. Bres, V., R. Kiernan, S. Emiliani, and M. Benkirane. 2002. Tat acetylacceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem. 277:22215-22221.
8. Brokstad, K., K. Kalland, W. Russell, and D. Matthews. 2001. Mitochondrial protein p32 can accumulate in the nucleus. Biochem. Biophys. Res. Commun. 281:1161-1169.
9. Bryant, H. E., D. A. Matthews, S. Wadd, J. E. Scott, J. Kean, S. Graham, W. C. Russell, and J. B. Clements. 2000. Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32. J. Virol. 74:11322-11328.
10. Calnan, B. J., S. Biancalana, D. Hudson, and A. D. Frankel. 1991. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes Dev. 5:201-210.
11. Calzado, M., R. Sancho, and E. Munoz. 2004. Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression. J. Virol. 78:6846-6854.
12. Chattopadhyay, C., D. Hawke, R. Kobayashi, and S. N. Maity. 2004. Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro. Nucleic Acids Res. 32:3632-3641.
13. Chen, D., M. Wang, S. Zhou, and Q. Zhou. 2002. HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J. 21:6801-6810.
14. Cho, D., G. Yang, C. Ryu, and H. Hong. 2003. Molecular chaperone GRP78/BiP interacts with the large surface protein of hepatitis B virus in vitro and in vivo. J. Virol. 77:2784-2788.
15. Cujec, T. P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin. 1997. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:2645-2657.
16. de la Fuente, C., L. Deng, F. Santiago, L. Arce, L. Wang, and F. Kashanchi. 2000. Gene expression array of HTLV type 1-infected T cells: up-regulation of transcription factors and cell cycle genes. AIDS Res. Hum. Retrovir. 16:1695-1700.
17. Deng, L., C. de la Fuente, P. Fu, L. Wang, R. Donnelly, J. D. Wade, P. Lambert, H. Li, C. G. Lee, and F. Kashanchi. 2000. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277:278-295.
18. Deng, L., D. Wang, C. de la Fuente, L. Wang, H. Li, C. G. Lee, R. Donnelly, J. D. Wade, P. Lambert, and F. Kashanchi. 2001. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology 289:312-326.
19. Desfosses, Y., M. Solis, Q. Sun, N. Grandvaux, C. Van Lint, A. Burny, A. Gatignol, M. Wainberg, R. Lin, and J. Hiscott. 2005. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins. J. Virol. 79:9180-9191.
20. Dorr, A., V. Kiermer, A. Pedal, H. R. Rackwitz, P. Henklein, U. Schubert, M. M. Zhou, E. Verdin, and M. Ott. 2002. Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J. 21:2715-2723.
21. Earl, P., B. Moss, and R. Doms. 1991. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65:2047-2055.
22. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
23. Fraldi, A., P. Licciardo, B. Majello, A. Giordano, and L. Lania. 2001. Distinct regions of cyclinT1 are required for binding to CDK9 and for recruitment to the HIV-1 Tat/TAR complex. J. Cell. Biochem. 81:247-253.
24. Furia, B., L. Deng, K. Wu, S. Baylor, K. Kehn, H. Li, R. Donnelly, T. Coleman, and F. Kashanchi. 2002. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J. Biol. Chem. 277:4973-4980.
25. Gabuzda, D., and W. J. 2000. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J. Neurovirol. 6:S24-32.
26. Gaughan, L., I. R. Logan, S. Cook, D. E. Neal, and C. N. Robson. 2002. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J. Biol. Chem. 277:25904-25913.
27. Ghose, R., L. Y. Lion, C. H. Herrmann, and A. P. Rice. 2001. Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines. J. Virol. 75:11336-11343.
28. Gorry, P. R., J. L. Howard, M. J. Churchill, J. L. Anderson, A. Cunningham, D. Adrian, D. A. McPhee, and D. F. Purcell. 1999. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev. J. Virol. 73:352-361.
29. Gutekunst, K. A., F. Kashanchi, J. N. Brady, and D. Bednarik. 1993. Transcription of the HIV-1 LTR is regulated by the density of DNA CpG methylation. J. Acquir. Immune Defic. Syndr. 6:541-549.
30. Hall, K. T., M. S. Giles, M. A. Calderwood, D. J. Goodwin, D. A. Matthews, and A. Whitehouse. 2002. The herpesvirus saimiri open reading frame 73 gene product interacts with the cellular protein p32. J. Virol. 76:11612-11622.
31. Hauber, J., M. H. Malim, and B. R. Cullen. 1989. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J. Virol. 63:1181-1187.
32. He, J., S. Choe, R. Walker, P. Di Marzio, D. O. Morgan, and N. R. Landau. 1995. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705-6711.
33. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
34. Hope, T., D. McDonald, X. Huang, J. Low, and T. Parslow. 1990. Mutational analysis of the human immunodeficiency virus type 1 Rev. transactivator: essential residues near the amino terminus. J. Virol. 64:5360-5366.
35. Huang, T. S., C. E. Nilsson, T. Punga, and G. Akusjarvi. 2002. Functional inactivation of the SR family of splicing factors during a vaccinia virus infection. EMBO Rep. 3:1088-1093.
36. Jacquenet, S., D. Decimo, D. Muriaux, and J. L. Darlix. 2005. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2:33.
37. Jordan, A., P. Defechereux, and E. Verdin. 2001. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20:1726-1738.
38. Kaehlcke, K., A. Dorr, C. Hetzer-Egger, V. Kiermer, P. Henklein, M. Schnoelzer, E. Loret, P. A. Cole, E. Verdin, and M. Ott. 2003. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol. Cell 12:167-176.
39. Kashanchi, F., S. N. Khleif, J. F. Duvall, M. R. Sadaie, M. F. Radonovich, M. Cho, M. A. Martin, S. Y. Chen, R. Weinmann, and J. N. Brady. 1996. Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex. J. Virol. 70:5503-5510.
40. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fattaey, C. M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature 367:295-299.
41. Kashanchi, F., R. Sbibata, E. K. Ross, J. N. Brady, and M. A. Martin. 1994. Second-site long terminal repeat (LTR) revenants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA. J. Virol. 68:3298-3307.
42. Kiernan, R. E., C. Vanhulle, L. Schlitz, E. Adam, H. Xiao, F. Maudoux, C. Calomme, A. Burny, Y. Nakatani, K. T. Jeang, M. Benkirane, and C. Van Lint. 1999. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18:6106-6118.
43. Kim, S. Y., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:3708-3713.
44. Klotman, M. E., S. Kim, A. Buchbinder, A. DeRossi, D. Baltimore, and F. Wong-Staal. 1991. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88:5011-5015.
45. Krainer, A., G. Conway, and D. Kozak. 1990. Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev. 4:1158-1171.
46. Krishnan, V., and S. Zeichner. 2004. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J. Virol. 78:9458-9473.
47. Kumar, P. P., P. K. Purbey, D. S. Ravi, D. Mitra, and S. Galande. 2005. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol. Cell. Biol. 25:1620-1633.
48. Laughlin, M. A., S. Zeichner, D. Kolson, J. C. Alwine, T. Seshamma, R. J. Pomerantz, and F. Gonzalez-Scarano. 1993. Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology 196:496-505.
49. Lewinski, M., D. Bisgrove, P. Shinn, H. Chen, C. Hoffmann, S. Hannenhalli, E. Verdin, C. Berry, J. Ecker, and F. Bushman. 2005. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79:6610-6619.
50. Liang, W., A. Maddukuri, T. Teslovich, C. De La Fuente, E. Agbottah, S. Dadgar, K. Kehn, S. Hautaniemi, A. Pumfery, D. Stephan, and F. Kashanchi. 2005. Therapeutic targets for HIV-1 infection in the host proteome. Retrovirology 2:20.
51. Luo, Y., H. Yu, and B. Peterlin. 1994. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68:3850-3856.
52. Marcello, A., M. Lusic, G. Pegoraro, V. Pellegrini, F. Beltram, and M. Giacca. 2004. Nuclear organization and the control of HIV-1 transcription. Gene 326:1-11.
53. Marcello, A., M. Zoppe, and M. Giacca. 2001. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life 51:175-181.
54. Marzio, G., M. Tyagi, M. I. Gutierrez, and M. Giacca. 1998. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA 95:13519-13524.
55. Matthews, D., and W. Russell. 1998. Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J. Gen. Virol. 79:1677-1685.
56. McPhillips, M., T. Veerapraditsin, S. Cumming, D. Karali, S. Milligan, W. Boner, I. Morgan, and S. Graham. 2004. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J. Virol. 78:10598-10605.
57. Michael, N. L., P. Morrow, J. Mosca, M. Vahey, D. S. Burke, and R. R. Redfield. 1991. Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J. Virol. 65:7084.
58. Michael, N. L., M. Vahey, D. S. Burke, and R. R. Redfield. 1992. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J. Virol. 66:310-316.
59. Michienzi, A., S. Li, J. A. Zaia, and J. J. Rossi. 2002. A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc. Natl. Acad. Sci. USA 99:14047-14052.
60. Molin, M., and G. Akusjarvi. 2000. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. J. Virol. 74:9002-9009.
61. Monneret, C. 2005. Histone deacetylase inhibitors. Eur. J. Med. Chem. 40:1-13.
62. Mujtaba, S., Y. He, L. Zeng, A. Farooq, J. E. Carlson, M. Ott, E. Verdin, and M. M. Zhou. 2002. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell 9:575-586.
63. Nisole, S., and A. Saib. 2004. Early steps of retrovirus replicative cycle. Retrovirology 1:9.
64. O'Keeffe, B., Y. Fong, D. Chen, S. Zhou, and Q. Zhou. 2000. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J. Biol. Chem. 275:279-287.
65. Ott, M., A. Dorr, C. Hetzer-Egger, K. Kaehlcke, M. Schnolzer, P. Henklein, P. A. Cole, M. Zhou, and E. Verdin. 2004. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. Novartis Found. Symp. 259:182-193.
66. Ott, M., M. Scbnolzer, J. Garnica, W. Fischle, S. Emiliani, H. R. Rackwitz, and E. Verdin. 1999. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9:1489-1492.
67. Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxyterminal domain. Nature 384:375-378.
68. Petersen-Mahrt, S., C. Estmer, C. Ohrmalm, D. Matthews, W. Russell, and G. Akusjani. 1999. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 18:1014.
69. Pomerantz, R. J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271-1276.
70. Pumfery, A., L. Deng, A. Maddukuri, C. de la Fuente, H. Li, J. D. Wade, P. Lambert, A. Kumar, and F. Kashanchi. 2003. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr. HIV Res. 1:343-362.
71. Purcell, D. F., and M. A. Martin. 1993. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67:6365-6378.
72. Raha, T., S. W. Cheng, and M. R. Green. 2005. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol. 3:e44.
73. Riggs, N., S. Little, D. Richman, and J. Guatelli. 1994. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors. Virology 202:264-271.
74. Robles-Flores, M., E. Rendon-Huerta, H. Gonzalez-Aguilar, G. Mendoza-Hernandez, S. Islas, V. Mendoza, M. Ponce-Castaneda, L. Gonzalez-Mariscal, and F. Lopez-Casillas. 2002. p32 (gC1qBP) is a general protein kinase C (PKC)-binding protein; interaction and cellular localization of P32-PKC complexes in ray hepatocytes. J. Biol. Chem. 277:5247-5255.
75. Roof, P., M. Ricci, P. Genin, M. Montano, M. Essex, M. Wainberg, A. Gatignol, and J. Hiscott. 2002. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 296:77-83.
76. Ropers, D., L. Ayadi, R. Gattoni, S. Jacquenet, L. Damier, C. Branlant, and J. Stevenin. 2004. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J. Biol. Chem. 279:29963-29973.
77. Santiago, F., E. Clark, S. Chong, C. Molina, F. Mozafari, R. Mahieux, M. Fujii, N. Azimi, and F. Kashanchi. 1999. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J. Virol. 73:9917-9927.
78. Sciabica, K. S., Q. J. Dai, and R. M. Sandri-Goldin. 2003. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J. 22:1608-1619.
79. Shen, H., and M. R. Green. 2004. A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly. Mol. Cell 16:363-373.
80. Shen, H., J. L. Kan, and M. R. Green. 2004. Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol. Cell 13:367-376.
81. Simos, G., and S. Georgatos. 1994. The lamin B receptor-associated protein p34 shares sequence homology and antigenic determinants with the splicing factor 2-associated protein p32. FEBS Lett. 346:225-228.
82. Siomi, H., H. Shida, M. Maki, and M. Hatanaka. 1990. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64:1803-1807.
83. Smith, J., A. Azad, and N. Deacon. 1992. Identification of two novel human immunodeficiency virus type 1 splice acceptor sites in infected T cell lines. J. Gen. Virol. 73:1825-1828.
84. Soltys, B. J., D. Rang, and R. S. Gupta. 2000. Localization of P32 protein (gC1q-R) in mitochondria and at specific extramitochondrial locations in normal tissues. Histochem. Cell Biol. 114:245-255.
85. Sonza, S., H. P. Mutimer, K. O'Brien, P. Ellery, J. L. Howard, J. H. Axelrod, N. J. Deacon, S. M. Crowe, and D. F. Purcell. 2002. Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages. J. Virol. 76:12611-12621.
86. Stauber, R. H., and G. N. Pavlakis. 1998. Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252:126-136.
87. Su, Y., J. Testaverde, C. Davis, W. Hayajneh, R. Adair, and A. Colberg-Poley. 2003. Human cytomegalovirus UL37 immediate early target mini-gene RNAs are accurately spliced and polyadenylated. J. Gen. Virol. 84:29-39.
88. Tange, T., T. Jensen, and J. Kjems. 1996. In vitro interaction between human immunodeficiency virus type 1 Rev. protein and splicing factor ASF/SF2-associated protein, p32. J. Biol. Chem. 271:10066-10072.
89. Tokunaga, K., A. Kojima, T. Kurata, K. Ikuta, H. Akari, A. H. Koyama, M. Kawamura, R. Inubushi, R. Shimano, and A. Adachi. 1998. Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent. J. Gen. Virol. 79:2447-2453.
90. Turner, B. G., and M. F. Summers. 1999. Structural biology of HIV. J. Mol. Biol. 285:1-32.
91. Veschambre, P., A. Roisin, and P. Jalinot. 1997. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. J. Gen. Virol. 78(Pt 9):2235-2245.
92. Veschambre, P., P. Simard, and P. Jalinot. 1995. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250:169-180.
93. Wang, J., and J. L. Manley. 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335-346.
94. Wang, Y., J. Finan, J. Middeldorp, and S. Hayward. 1997. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 236:18-29.
95. Weissman, J. D., J. A. Brown, T. K. Howcroft, J. Hwang, A. Chawla, P. A. Roche, L. Schiltz, Y. Nakatani, and D. S. Singer. 1998. HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc. Natl. Acad. Sci. USA 95:11601-11606.
96. Westendorp, M. O., V. A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Droge, and V. Lehmann. 1995. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:546-554.
97. Wu, K., M. E. Bottazzi, C. de La Fuente, L. Deng, S. D. Gitlin, A. Maddukuri, H. Li, A. Vertes, A. Pumfery, and F. Kashanchi. 2004. Protein profile of Tax-associated complexes. J. Biol. Chem. 279:495-508.
98. Reference deleted.
99. Yang, X. J. 2004. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26:1076-1087.
100. Yao, Q., R. W. Compans, and C. Chen. 2001. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Virology 285:128-137.
101. Yedavalli, V., C. Neuveut, Y. Chi, L. Kleiman, and K. Jeang. 2004. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119:381-392.
102. Yu, L., Z. Zhang, P. Loewenstein, K. Desai, Q. Tang, D. Mao, J. Symington, and M. Green. 1995. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 TAT transactivator and encodes a strong transcriptional activation domain. J. Virol. 69:3007-3016.
103. Zapp, M., and M. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev. protein. Nature 342:714-716.
104. Zheng, Y., H. Yu, and B. Peterlin. 2003. Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat. Cell Biol. 5:611-618.
105. Zhou, M., M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady. 2000. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20:5077-5086.
106. Zhou, M., F. Kashanchi, H. Jiang, H. Ge, and J. N. Brady. 2000. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat. Virology 268:452-460.
107. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:2622-2632.